Amarin Corp Plcuk (AMRN) Construction in Progress (2011 - 2016)

Amarin Corp Plcuk (AMRN) reported Construction in Progress of $12000.0 for Q4 2016, down 83.33% quarter-over-quarter from $72000.0 in Q4 2012.

Amarin Corp Plcuk (AMRN) Construction in Progress (2011 - 2016) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 3 years of Construction in Progress data on file, last reported at $12000.0 in Q4 2016.

Construction in Progress for Q4 2016 came in at $12000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $12000.0 (changed N/A YoY), and the FY2016 annual result was $12000.0, changed N/A from the prior year.
Construction in Progress eased to $12000.0 in Q4 2016 per AMRN's latest filing, from $72000.0 in the prior quarter.
Over five years, Construction in Progress peaked at $72000.0 in Q4 2012 and troughed at $12000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Construction in Progress (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	-
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	-
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	-
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	-
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	-
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	-
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	-
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	1.54 Bn
10	Amarin Corp Plcuk	6.77 Bn	6.59 Bn	17.77 Mn	-

Download Data